ProPhase Labs Inc (PRPH)
2.19
+0.05
(+2.34%)
USD |
NASDAQ |
Nov 04, 16:00
2.19
0.00 (0.00%)
After-Hours: 20:00
ProPhase Labs Shareholders Equity (Quarterly): 44.08M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 44.08M |
March 31, 2024 | 44.87M |
December 31, 2023 | 49.38M |
September 30, 2023 | 56.43M |
June 30, 2023 | 59.26M |
March 31, 2023 | 59.94M |
December 31, 2022 | 63.63M |
September 30, 2022 | 67.92M |
June 30, 2022 | 68.16M |
March 31, 2022 | 66.44M |
December 31, 2021 | 58.63M |
September 30, 2021 | 48.26M |
June 30, 2021 | 47.73M |
March 31, 2021 | 52.66M |
December 31, 2020 | 10.56M |
September 30, 2020 | 10.76M |
June 30, 2020 | 10.89M |
March 31, 2020 | 10.63M |
December 31, 2019 | 11.23M |
September 30, 2019 | 14.40M |
June 30, 2019 | 14.65M |
March 31, 2019 | 15.70M |
December 31, 2018 | 16.50M |
September 30, 2018 | 19.70M |
June 30, 2018 | 20.53M |
Date | Value |
---|---|
March 31, 2018 | 33.12M |
December 31, 2017 | 31.85M |
September 30, 2017 | 36.65M |
June 30, 2017 | 46.63M |
March 31, 2017 | 50.67M |
December 31, 2016 | 5.962M |
September 30, 2016 | 6.534M |
June 30, 2016 | 6.367M |
March 31, 2016 | 7.494M |
December 31, 2015 | 8.829M |
September 30, 2015 | 10.04M |
June 30, 2015 | 8.362M |
March 31, 2015 | 9.37M |
December 31, 2014 | 10.72M |
September 30, 2014 | 10.54M |
June 30, 2014 | 13.61M |
March 31, 2014 | 12.80M |
December 31, 2013 | 12.60M |
September 30, 2013 | 11.63M |
June 30, 2013 | 10.30M |
March 31, 2013 | 11.98M |
December 31, 2012 | 11.45M |
September 30, 2012 | 9.891M |
June 30, 2012 | 8.772M |
March 31, 2012 | 10.63M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.56M
Minimum
Dec 2020
68.16M
Maximum
Jun 2022
44.29M
Average
49.38M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
Fonar Corp | 165.97M |
XWELL Inc | 8.798M |
Applied DNA Sciences Inc | 12.39M |
Veracyte Inc | 1.133B |
OncoCyte Corp | 22.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 93.68M |
Total Liabilities (Quarterly) | 49.60M |
Debt to Equity Ratio | 0.3083 |
Current Ratio | 1.576 |
Net Debt Paydown Yield | -0.99% |